Foreign-Trade Zone (FTZ) 230, Notification of Proposed Production Activity; Patheon Softgels; (Pharmaceutical Products); High Point, North Carolina, 51873 [2024-13449]
Download as PDF
Federal Register / Vol. 89, No. 119 / Thursday, June 20, 2024 / Notices
operation of a nationwide interoperable
public safety broadband network. The
FirstNet Authority Board is responsible
for making strategic decisions regarding
the operations of the FirstNet Authority.
Matters to be Considered: The
FirstNet Authority will post a detailed
agenda for the Combined Board and
Board Committees Meeting on
FirstNet.gov prior to the meeting. The
agenda topics are subject to change.
Please note that the subjects discussed
by the Board and Board Committees
may involve commercial or financial
information that is privileged or
confidential, or other legal matters
affecting the FirstNet Authority. As
such, the Board may, by majority vote,
close the meeting only for the time
necessary to preserve the confidentiality
of such information, pursuant to 47
U.S.C. 1424(e)(2).
Other Information: The public
Combined Board and Board Committees
Meeting is accessible to people with
disabilities. Individuals requiring
accommodations, such as sign language
interpretation or other ancillary aids, are
asked to notify Jennifer Watts at (571)
665–6178 or email: Jennifer.Watts@
FirstNet.gov before the meeting.
Records: The FirstNet Authority
maintains records of all Board
proceedings. Minutes of the Combined
Board and Board Committees Meeting
will be available on FirstNet.gov.
Dated: June 14, 2024.
Jennifer Watts,
Board Secretary, First Responder Network
Authority.
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–33–2024]
khammond on DSKJM1Z7X2PROD with NOTICES
Foreign-Trade Zone 75; Application for
Expansion of Subzone 75C; Intel
Corporation; Phoenix, Arizona
An application has been submitted to
the Foreign-Trade Zones (FTZ) Board by
the City of Phoenix, grantee of FTZ 75,
requesting an expansion of Subzone 75C
on behalf of Intel Corporation. The
application was submitted pursuant to
the provisions of the Foreign-Trade
Zones Act, as amended (19 U.S.C. 81a–
81u), and the regulations of the FTZ
Board (15 CFR part 400). It was formally
docketed on June 13, 2024.
The applicant is requesting authority
to expand the subzone to include a new
site located at 3929 West Lower
Buckeye Road, Phoenix (Site 6—1.7
acres).
Jkt 262001
[FR Doc. 2024–13451 Filed 6–18–24; 8:45 am]
BILLING CODE 3510–DS–P
the Board previously approved for the
operation, as reflected on the Board’s
website.
The proposed finished products
include CU06–1004 and northenindrone
acetate (duty-free).
The proposed foreign-status
materials/components include: CU06–
1004(active pharmaceutical ingredient);
titanium dioxide (35%); mono
diglycerides; surfactants; glycerol
monolinoneate; red iron oxide; yellow
iron oxide; medium chain triglycerides;
vitamin E; sesame oil nf; linoleoyl
polyoxyl-6 glycerides; ethinylestradiol
micronized; glycerin and
northenindrone acetate (active
pharmaceutical ingredient) (duty rate
ranges from duty-free to 6.5%).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is July
30, 2024.
A copy of the notification will be
available for public inspection in the
‘‘Online FTZ Information System’’
section of the Board’s website.
For further information, contact
Kolade Osho at Kolade.Osho@trade.gov.
Foreign-Trade Zones Board
Dated: June 13, 2024.
Elizabeth Whiteman,
Executive Secretary.
[B–31–2024]
[FR Doc. 2024–13449 Filed 6–18–24; 8:45 am]
DEPARTMENT OF COMMERCE
BILLING CODE 3510–DS–P
BILLING CODE P
17:08 Jun 18, 2024
Dated: June 14, 2024.
Elizabeth Whiteman,
Executive Secretary.
Foreign-Trade Zone (FTZ) 230,
Notification of Proposed Production
Activity; Patheon Softgels;
(Pharmaceutical Products); High Point,
North Carolina
[FR Doc. 2024–13499 Filed 6–18–24; 8:45 am]
VerDate Sep<11>2014
In accordance with the FTZ Board’s
regulations, Qahira El-Amin of the FTZ
Staff is designated examiner to review
the application and make
recommendations to the FTZ Board.
Public comment is invited from
interested parties. Submissions shall be
addressed to the FTZ Board’s Executive
Secretary and sent to: ftz@trade.gov. The
closing period for their receipt is July
30, 2024. Rebuttal comments in
response to material submitted during
the foregoing period may be submitted
during the subsequent 15-day period to
August 14, 2024.
A copy of the application will be
available for public inspection in the
‘‘Online FTZ Information Section’’
section of the FTZ Board’s website,
which is accessible via www.trade.gov/
ftz.
For further information, contact
Qahira El-Amin at Qahira.El-Amin@
trade.gov.
51873
The Piedmont Triad Partnership,
grantee of FTZ 230, submitted a
notification of proposed production
activity to the FTZ Board (the Board) on
behalf of Patheon Softgels (Patheon), for
Patheon’s facility in High Point, North
Carolina within Subzone 230C. The
notification conforming to the
requirements of the Board’s regulations
(15 CFR 400.22) was received on June
12, 2024.
Pursuant to 15 CFR 400.14(b), FTZ
production activity would be limited to
the specific foreign-status material(s)/
component(s) and specific finished
product(s) described in the submitted
notification (summarized below) and
subsequently authorized by the Board.
The benefits that may stem from
conducting production activity under
FTZ procedures are explained in the
background section of the Board’s
website—accessible via www.trade.gov/
ftz. The proposed finished product(s)
and material(s)/component(s) would be
added to the production authority that
PO 00000
Frm 00004
Fmt 4703
Sfmt 4703
DEPARTMENT OF DEFENSE
Office of the Secretary
[Docket ID: DoD–2024–HA–0068]
Proposed Collection; Comment
Request
The Office of the Assistant
Secretary of Defense for Health Affairs
(OASD(HA)), Department of Defense
(DoD).
ACTION: 60-Day information collection
notice.
AGENCY:
In compliance with the
Paperwork Reduction Act of 1995, the
Defense Health Agency (DHA)
announces a proposed public
information collection and seeks public
comment on the provisions thereof.
Comments are invited on: whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information shall have
practical utility; the accuracy of the
agency’s estimate of the burden of the
proposed information collection; ways
to enhance the quality, utility, and
SUMMARY:
E:\FR\FM\20JNN1.SGM
20JNN1
Agencies
[Federal Register Volume 89, Number 119 (Thursday, June 20, 2024)]
[Notices]
[Page 51873]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-13449]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-31-2024]
Foreign-Trade Zone (FTZ) 230, Notification of Proposed Production
Activity; Patheon Softgels; (Pharmaceutical Products); High Point,
North Carolina
The Piedmont Triad Partnership, grantee of FTZ 230, submitted a
notification of proposed production activity to the FTZ Board (the
Board) on behalf of Patheon Softgels (Patheon), for Patheon's facility
in High Point, North Carolina within Subzone 230C. The notification
conforming to the requirements of the Board's regulations (15 CFR
400.22) was received on June 12, 2024.
Pursuant to 15 CFR 400.14(b), FTZ production activity would be
limited to the specific foreign-status material(s)/component(s) and
specific finished product(s) described in the submitted notification
(summarized below) and subsequently authorized by the Board. The
benefits that may stem from conducting production activity under FTZ
procedures are explained in the background section of the Board's
website--accessible via www.trade.gov/ftz. The proposed finished
product(s) and material(s)/component(s) would be added to the
production authority that the Board previously approved for the
operation, as reflected on the Board's website.
The proposed finished products include CU06-1004 and northenindrone
acetate (duty-free).
The proposed foreign-status materials/components include: CU06-
1004(active pharmaceutical ingredient); titanium dioxide (35%); mono
diglycerides; surfactants; glycerol monolinoneate; red iron oxide;
yellow iron oxide; medium chain triglycerides; vitamin E; sesame oil
nf; linoleoyl polyoxyl-6 glycerides; ethinylestradiol micronized;
glycerin and northenindrone acetate (active pharmaceutical ingredient)
(duty rate ranges from duty-free to 6.5%).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary and sent to:
[email protected]. The closing period for their receipt is July 30, 2024.
A copy of the notification will be available for public inspection
in the ``Online FTZ Information System'' section of the Board's
website.
For further information, contact Kolade Osho at
[email protected].
Dated: June 13, 2024.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2024-13449 Filed 6-18-24; 8:45 am]
BILLING CODE 3510-DS-P